Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 65 for Interstitial lung disease 2
  1. Idiopathic pulmonary fibrosis 
    ... National Organization for Rare Disorders (NORD) ClinicalTrials.gov INTERSTITIAL LUNG DISEASE 2; ILD2 PubMed Allen RJ, Guillen-Guio B, Oldham ... 1):646-64. doi: 10.1164/ajrccm.161.2.ats3-00. No abstract available. Citation on ... Interstitial Lung Diseases: From Molecules to Clinical Implications. Int J Mol ...
    https://medlineplus.gov/.../condition/idiopathic-pulmonary-fibrosis - Genetics
  2. SFTPC gene 
    ... SMDP2 SP-C SP5 Tests of SFTPC PubMed INTERSTITIAL LUNG DISEASE 2; ILD2 SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C; SFTPC NCBI ...
    https://medlineplus.gov/genetics/gene/sftpc - Genetics
  3. Pulmonary Fibrosis Foundation (Pulmonary Fibrosis Foundation)  
    ... 2,000 Participants Impacted by Pulmonary Fibrosis and Interstitial Lung Disease Read Full Article PFF Community Registry Reaches Milestone of 2,000 Participants Impacted by Pulmonary Fibrosis and Interstitial ...
    https://www.pulmonaryfibrosis.org - Other Resources
  4. FLNA gene 
    ... A review of filamin A mutations and associated interstitial lung disease. Eur J Pediatr. 2019 Feb;178(2):121-129. doi: 10.1007/s00431-018-3301- ... Ehlers-Danlos syndrome. Neurology. 2005 Jan 25;64(2):254-62. doi: ... lung disease (ChILD) classification. Pediatr Pulmonol. 2017 Oct;52(10): ...
    https://medlineplus.gov/genetics/gene/flna - Genetics
  5. Tocilizumab Injection 
    ... subcutaneously (Actemra, Tyenne) once every week or every 2 or 3 weeks. When tocilizumab injection products are given to treat systemic sclerosis-associated interstitial lung disease, they are usually given subcutaneously (Actemra) once weekly. ...
    https://medlineplus.gov/druginfo/meds/a611004.html - Drugs and Supplements
  6. NKX2-1 gene 
    ... mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome". Hum Mutat. 2010 Feb;31(2):E1146-62. doi: 10.1002/humu.21183. Citation ...
    https://medlineplus.gov/genetics/gene/nkx2-1 - Genetics
  7. Brain-lung-thyroid syndrome 
    ... mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome". Hum Mutat. 2010 Feb;31(2):E1146-62. doi: 10.1002/humu.21183. Citation ...
    https://medlineplus.gov/.../condition/brain-lung-thyroid-syndrome - Genetics
  8. Surfactant dysfunction 
    ... no history of the disorder in their family. ... pulmonary, 2 Genetic Testing Registry: Surfactant metabolism dysfunction, pulmonary, 4 ...
    https://medlineplus.gov/genetics/condition/surfactant-dysfunction - Genetics
  9. TERC gene 
    ... AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2; PFBMFT2 NCBI Gene ClinVar Arish N, Petukhov D, Wallach-Dayan SB. The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications. Int J Mol ...
    https://medlineplus.gov/genetics/gene/terc - Genetics
  10. Arthritis by the Numbers: Book of Trusted Facts and Figures (Arthritis Foundation) - PDF  
    Arthritis/Statistics and Research ... Arthritis ... Gout/Statistics and Research ... Gout ... Scleroderma/Statistics and Research ... Scleroderma ... Rheumatoid Arthritis/Statistics ...
    https://www.arthritis.org/.../abtn-2020-final.pdf - External Health Links
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · next